Akcea Therapeutics, Inc. announced that Michael D. Price has joined the company as executive vice president and chief financial officer. In this role, Mr. Price will oversee financial operations at the company including managing financial strategies and activities related to clinical and regulatory functions, commercial sales, marketing, manufacturing and supply chain. Mr. Price has more than 25 years of experience in the pharmaceutical industry.

Before joining Akcea, Mr. Price served as executive vice president and chief financial officer and was elected to the company's board of directors of Novelion Therapeutics.